The Australian Pharmaceutical Biostatistics Group cordially invites SSA members to attend our free in-person and online estimands event on 19th May! The estimand framework was published as ICH E9 (R1) in 2019, however since that time there has been some uncertainty about how to implement the framework in practice. At this meeting, you will have the opportunity to view the PSI's Expert Interest Working Group's webinar on Estimands in Oncology - How and Why while participating in live polling and discussion.
Please find all the details below and on our APBG website. We look forward to seeing you there!
Date/Time
Friday 19th May 2023, 2.30-5.00pm
Location
Macquarie University City Campus
Room 2414, Level 24, 123 Pitt Street, Sydney NSW 2000
Agenda
2.30pm Arrival tea and coffee
2.45pm Screening of PSI EIWG Webinar (Part 1)
3.30pm Afternoon tea and networking
3.50pm Screening of PSI EIWG Webinar (Part 2)
4.35pm General Discussion
5.00pm Meeting Close
RSVP
Please RSVP by 12th May 2023 to this free event by emailing apbgsteering@gmail.com.
Details of PSI EIWG Webinar - Estimands in Oncology - How and Why (to be rescreened during the event)
During this webinar, you will be guided through a case study (CheckMate 037) and interactively deepen the knowledge to gain hands-on experience in developing estimands. You will be introduced to the background and disease context of the case study, the concept of an estimand, and important clinical events (increased dropout rate and crossover therapy) that occurred in the trial and affected interpretation of the results. Using non-technical language and clear graphical presentation of the concepts, you will experience how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials. Target audience (no prior knowledge in oncology or of estimands required): Clinicians, Investigators, Regulatory Experts, Medical Writers, Ethics Committees, Statisticians.
@StatSocAus
